Haemodynamic events and localised parenchymal changes following transcatheter arterial chemoembolisation for hepatic malignancy: Interpretation of imaging findings

British Journal of Radiology

Volumn 83, Issue 985, 2010, Pages 71-81

  Chung, J ^a   Yu, Jeong Sik ^a   Chung, J J ^a   Kim, J H ^a   Kim, K W ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS FISTULA; BILE DUCT INJURY; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HEMODYNAMICS; HUMAN; IMAGE ANALYSIS; LIVER ARTERIOVENOUS FISTULA; LIVER ATROPHY; LIVER CELL CARCINOMA; LIVER ISCHEMIA; LIVER PARENCHYMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN OBSTRUCTION; REVIEW;

AGED; ARTERIOVENOUS FISTULA; ATROPHY; BILE DUCT DISEASES; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEMODYNAMICS; HUMANS; INFARCTION; LIVER; LIVER CIRCULATION; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PORTAL VEIN; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 76149112257     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/82377365     Document Type: Review

References (10)

1. Charnsangavej C, Chuang V, Wallace S, Soo C, Bowers T. Transcatheter management of primary carcinoma of the liver. Radiology 1983;147:51-5.
2. Wallace S, Charnsangavej C, Carrasco CH, Bechtel W. Infusion- embolization. Cancer 1984;54:2751-65.
3. Uchida H, Ohishi H, Matsuo N, Nishimine K, Ohue S, Nishimura Y, et al. Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma. Cardiovasc Intervent Radiol 1990;13:140-5.
4. Yu JS, Kim KW, Park MS, Yoon SW. Bile duct injuries leading to portal vein obliteration after transcatheter arterial chemoembolization in the liver: CT findings and initial observations. Radiology 2001;221:429-36.
5. Kim HK, Chung YH, Song BC, Yang SH, Yoon HK, Yu ES, et al. Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 2001;32: 423-7.
6. Yu JS, Kim KW, Jeong MG, Lee DH, Park MS, Yoon SW. Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy. Cardiovasc Intervent Radiol 2002;25:270-4.
7. Shea WJ Jr, Demas BE, Goldberg HI, Hohn DC, Ferrell LD, Kerlan RK. Sclerosing Cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic histologic correlation. AJR Am J Roentgenol 1986;146:717-21.
8. Yu JS, Kim KW, Sung KB, Lee JT, Yoo HS. Small arterial-portal venous shunts: a cause of pseudolesions at hepatic imaging. Radiology 1997;203:737-42.
9. Mori K, Yoshioka H, Itai Y, Okamoto Y, Mori H, Takahashi N, et al. Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. Am J Roentgenol 2000;175:1659-64.
10. Yamashita Y, Torashima M, Oguni T, Yamamoto A, Harada M, Miyazaki T, et al. Liver parenchymal changes after transcatheter arterial embolization therapy for hepatoma: CT evaluation. Abdom Imaging 1993;18:352-6.